跳至主要内容
临床试验/SLCTR/2007/002
SLCTR/2007/002招募中未知

Prospective double blind randomized placebo controlled trial on the efficacy of metformin in the treatment of NASH

Faculty of Medicine, University of Kelaniya,0 个研究点目标入组 170 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • * Patients with clinical, biochemical, radiological and histological evidence of NASH * No history of other possible aetiological factors for steatohepatitis such as significant alcohol consumption, medications

排除标准

  • * Patients with diabetes mellitus * Patients with significantly elevated levels of total cholesterol and triglycerides requiring lipid lowering treatment * Patients with severe obesity * Patients with history of significant alcohol ingestion. *patients with history of taking medications known to cause NASH. * Patients with any other liver diseases * Patients with contraindications for metformin * Pregnant females * All patients with contraindications for liver biopsy

研究者

相似试验